Journal of Pediatric Perspectives

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Effectiveness of Melatonin in combination with Sildenafil in treatment of intrauterine growth restriction: a double-blind, randomized clinical trial

Document Type : original article

Authors

1 Assistant Professor of Obstetrics and Gynecology Department of Obstetrics and Gynecology, School of Medicine Social Determinants of Health Research Center Yasuj University of Medical Sciences.

2 Assistant Professor of Obstetrics and Gynecology Department of Obstetrics and Gynecology, School of Medicine Yasuj University of Medical Sciences.

3 Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.

4 Department of Gynecology and Obstetrics, Yasuj University of Medical Sciences, Yasuj, Iran.

Abstract

Background: Intrauterine Growth Restriction (IUGR) is a common obstetrical diagnosis associated with high risks of perinatal mortality and morbidity. Some studies have suggested that either sildenafil or melatonin may improve IUGR outcomes; but we found no evidence on the effects of concomitant sildenafil and melatonin therapy on IUGR fetuses. Therefore, the aim of the present study was to investigate whether simultaneous intake of melatonin and sildenafil can be more effective in alleviating IUGR outcomes.
Methods: Patients with idiopathic IUGR referred to Yasuj Women's Clinic during 2019 and 2021 were enrolled in the current double-blind, randomized clinical trial. Out of 140 participants, a total of 120 pregnant women were included, 100 pregnant women with confirmed IUGR (gestational age between 26 to 32 weeks) were randomly assigned into four groups as fellows: sildenafil group (25 mg three times a day), melatonin (3 mg three times a day), sildenafil plus melatonin, and placebo. The patients received the drugs for at least 4 weeks. Doppler ultrasound was used to evaluate some outcomes on factors such as fetal weight, systolic/diastolic (S/D), PI, and RI of the umbilical, cerebral and uterine arteries. Neonatal outcomes (anthropometric characteristics of the infant, Apgar scores, meconium aspiration, and NICU admission) were also recorded.
Results: S/D of the middle cerebral artery was lower in the sildenafil plus melatonin subjects than in the other groups (p< 0.05). Sildenafil plus melatonin significantly increased infant weight and decreased the risks of preeclampsia and hospitalization compared to other treatments (p < 0.05).
Conclusion: The results confirmed that the concomitant prescription of melatonin and sildenafil increases birth weight, normalizes middle cerebral artery indices, and reduces the incidence of preeclampsia and neonatal hospitalization for IUGR. Therefore, Melatonin plus sildenafil can be a simple and economic treatment for IUGR.

Keywords

References
  1. Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction - part 1. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2016;29(24):3977-87.
  2. Kesavan K, Devaskar SU. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes. Pediatric clinics of North America. 2019; 66(2):403-23.
  3. Pels A, Beune IM, van Wassenaer‐Leemhuis AG, Limpens J, Ganzevoort W. Early‐onset fetal growth restriction: A systematic review on mortality and morbidity. Acta obstetricia et gynecologica Scandinavica. 2020; 99(2):153-66.
  4. Severi FM, Rizzo G, Bocchi C, D'Antona D, Verzuri MS, Arduini D. Intrauterine growth retardation and fetal cardiac function. Fetal Diagn Ther. 2000; 15(1):8-19.
  5. Pels A, Derks J, Elvan-Taspinar A, van Drongelen J, de Boer M, Duvekot H, Laar Jv, Eyck Jv, Al-Nasiry S, Sueters M, Post M, Onland W, Wassenaer-Leemhuis Av, Naaktgeboren C, Jakobsen Jc, Gluud C, Duijnhoven RG, Lely T, Gordijn S, Ganzevoort W; Dutch STRIDER Trial Group. Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA network open. 2020; 3(6):e205323-e.
  6. Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol. 2011; 204(4):288-300.
  7. Massimiani M, Tiralongo GM, Salvi S, Fruci S, Lacconi V, La Civita F, Mancini M, Stuhlmann H, Valensise H, Campagnolo L. Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study. Translational research: the journal of laboratory and clinical medicine. 2021; 228:28-41.
  8. Miller SL, Yawno T, Alers NO, Castillo-Melendez M, Supramaniam VG, VanZyl N, Sabaretnam T, Loose JM, Drummond GR, Walker DW, Jenkin G, Wallace EM. Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. Journal of pineal research. 2014; 56(3):283-94.
  9. Sharp A, Cornforth C, Jackson R, Harrold J, Turner MA, Kenny LC, Baker PN, Johnstone ED, Khalil A, Dadelszen Pv, Papageorghiou AT, Alfirevic Z; STRIDER group. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. The Lancet Child & adolescent health. 2018; 2(2):93-102.
  10. Eshraghi N, Mohamadianamiri M, Ebrahimi M, Karimi F. The Effect of Sildenafil on Intrauterine Growth Restriction (IUGR) of Fetus with Gestational Age above 28 Weeks and Neonatal Outcomes. International Journal of Pediatrics. 2021; 9(6):13643-51.
  11. Yi WJ, Kim TS. Melatonin protects mice against stress-induced inflammation through enhancement of M2 macrophage polarization. Int Immunopharmacol. 2017; 48:146-58.
  12. Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, Fougerou C. Melatonin: pharmacology, functions and therapeutic benefits. Current neuropharmacology. 2017; 15(3):434-43.
  13. Berbets A, Koval H, Barbe A, Albota O, Yuzko O. Melatonin decreases and cytokines increase in women with placental insufficiency. The Journal of Maternal-Fetal & Neonatal Medicine. 2021; 34(3):373-8.
  14. Berbets AM, Davydenko IS, Barbe AM, Konkov DH, Albota OM, Yuzko OM. Melatonin 1A and 1B receptors’ expression decreases in the placenta of women with fetal growth restriction. Reproductive Sciences. 2021; 28(1):197-206.
  15. Aynaoglu Yildiz G, Yildiz D, Yapca OE, Suleyman B, Arslan YK, Kurt N, Suleyman H. Effect of diazepam, sertraline and melatonin on the stress-induced reproductive disorders and intrauterine growth restriction in female rats. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2021;34(24):4103-9.
  16. Palmer KR, Mockler JC, Davies-Tuck ML, Miller SL, Goergen SK, Fahey MC, Anderson PJ, Groom KM, Wallace EM. Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction. BMJ open. 2019; 9(6):e028243.
  17. Maged M, Wageh A, Shams M, Elmetwally A. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial. Taiwanese journal of obstetrics & gynecology. 2018; 57(4):483-6.
  18. Shrestha A, Pradhan N, Kayastha B. Risk factors for intrauterine growth restriction: 9 years analysis in tertiary care hospital. Journal of BP Koirala Institute of Health Sciences. 2019; 2(1):77-82.
  19. Darendeliler F. IUGR: Genetic influences, metabolic problems, environmental associations/triggers, current and future management. Best practice & research Clinical endocrinology & metabolism. 2019; 33(3):101260.
  20. Oyston C, Baker PN. Therapeutic strategies for the prevention and treatment of pre-eclampsia and intrauterine growth restriction. Obstetrics, Gynaecology & Reproductive Medicine. 2017; 27(1):22-8.
  21. Garcia-Contreras C, Vazquez-Gomez M, Pesantez-Pacheco JL, Torres-Rovira L, Heras-Molina A, Encinas T, Astiz S, Gonzalez-Bulnes A. Maternal metformin treatment improves developmental and metabolic traits of IUGR fetuses. Biomolecules. 2019; 9(5):166.
  22. Shehata NA, Ali HA, Fahim AS, Katta MA, Hussein GK. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine. 2020; 33(10):1631-7.
  23. Damghanian M, Farnam F, Kharaghani R. The Effects of Sildenafil on Fetal Doppler Indices: A Systematic Review and Meta-Analysis. J-Adv-Med-Biomed-Res. 2020; 28(131):307-15.
  24. Xu Z, Wu Y, Zhang Y, Zhang H, Shi L. Melatonin activates BKCa channels in cerebral artery myocytes via both direct and MT receptor/PKC-mediated pathway. European Journal of Pharmacology. 2019; 842:177-88.
  25. Bazyar H, Gholinezhad H, Moradi L, Salehi P, Abadi F, Ravanbakhsh M, Zare Javid A. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial. Inflammopharmacology. 2019; 27(1):67-76.
  26. Zuo J, Jiang Z. Melatonin attenuates hypertension and oxidative stress in a rat model of L-NAME-induced gestational hypertension. Vascular Medicine. 2020; 25(4):295-301.
  27. Thakor AS, Herrera EA, Serón‐Ferré M, Giussani DA. Melatonin and vitamin C increase umbilical blood flow via nitric oxide‐dependent mechanisms. Journal of pineal research. 2010; 49(4):399-406.
  28. Lemley CO, Meyer AM, Camacho LE, Neville TL, Newman DJ, Caton JS, Vonnahme KA. Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2012; 302(4):R454-R67.
  29. McCarty KJ, Owen MPT, Hart CG, Thompson RC, Burnett DD, King EH, Hopper RM, Lemley CO. Effect of chronic melatonin supplementation during mid to late gestation on maternal uterine artery blood flow and subsequent development of male offspring in beef cattle. Journal of Animal Science. 2018; 96(12):5100-11.
  30. Contreras-Correa ZE, Messman RD, Sidelinger DR, Heath King E, Sánchez-Rodríguez HL, Burnett DD, Lemley CO. Melatonin alters bovine uterine artery hemodynamics, vaginal temperatures, and fetal morphometrics during late gestational nutrient restriction in a season-dependent manner. Journal of Animal Science. 2021; 99(9):skab242.
  31. Shehata NAA, Ali HAA, Fahim AS, Katta MA, Hussein GK. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2020;33(10):1631-7.
  32. El Darwish AA, Badawy MA, Farghaly SM. Sildenafil citrate therapy for IUGR and its effect on umbilical artery Doppler, Al-Azhar Assiut Med. J. 2020;18(3):227-32.
  33. Berbets AM, Barbe AM, Andriiets OA, Andriiets AV, Yuzko OM. Melatonin levels decrease in the umbilical cord in case of intrauterine growth restriction. Journal of medicine and life. 2020; 13(4):548.
  34. Choudhary R, Desai K, Parekh H, Ganla K. Sildenafil citrate for the management of fetal growth restriction and oligohydramnios. International journal of women's health. 2016; 8:367.
  35. González-Candia A, Veliz M, Araya C, Quezada S, Ebensperger G, Serón-Ferré M, Reyes RV, Llanos AJ, Herrera EA. Potential adverse effects of antenatal melatonin as a treatment for intrauterine growth restriction: findings in pregnant sheep. American Journal of Obstetrics and Gynecology. 2016; 215(2):245. e1-. e7.
  36. Turner J, Dunn L, Tarnow-Mordi W, Flatley C, Flenady V, Kumar S. Safety and efficacy of sildenafil citrate to reduce operative birth for intrapartum fetal compromise at term: a phase 2 randomized controlled trial. American Journal of Obstetrics and Gynecology. 2020; 222(5):401-14.
  37. Bulani G, Inamdar S, Chawla A. Comparative study of sildenafil citrate therapy versus low dose aspirin in early intrauterine growth restriction. 2017. 
Journal of Pediatric Perspectives
Volume 11, Issue 8
August 2023
Pages 18123-18136
Files
Share
How to cite
Statistics